| 2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine Basic information |
| 英文名 |
2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine |
| 别名 |
2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine;Primycin [inn] |
| CAS编号 |
47917-41-9 |
| 分子式 |
C55H103N3O17 |
| 分子量 |
0 |
| EINECS |
|
| Other Registry Numbers |
|
| IUPA Names, InChI, InChI Key, Canonical SMILES, etc.: |
IUPA Names, InChI, InChI Key, Canonical SMILES, etc. |
![2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine CAS#: 47917-41-9](/wp-content/uploads/2018/04/2-5-4E20E-35-butyl-19-2S3S4R5R-34-dihydroxy-5-hydroxymethyloxolan-2-yloxy-101214161822263034-nonahydroxy-352133-tetramethyl-36-oxo-1-oxacyclohexatriaconta-420-dien-2-yl-4-hydroxy-hexylguanidine-CAS-47917-41-9.gif) |
| 2-[5-[(4E,20E)-35-butyl-19-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxy-hexyl]guanidine Chemical Properties |
